» Articles » PMID: 24622160

Timing and Duration of Intracranial Hypertension Versus Outcomes After Severe Traumatic Brain Injury

Overview
Specialty Anesthesiology
Date 2014 Mar 14
PMID 24622160
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The goal of this paper was to investigate the association between patterns of intracranial hypertension (IH) and outcomes, to describe the treatment of patients with different patterns of IH, and to examine whether IH is an independent predictor of mortality and unfavourable outcome, respectively.

Methods: A retrospective analysis of data collected prospectively in 9 central European centers is presented. 204 patients with severe TBI who had intracranial pressure (ICP) monitoring were coded as having either early (within first 2 days), late (after first 2 days), or no IH. IH was defined as >60 min of ICP >20 mmHg/day. The total number of hours/day of IH was recorded. Treatment was followed closely for the first 10 days using the therapy intensity level (TIL) score. Associations between types of IH and demographic factors, trauma severity, or treatment factors as well as outcomes were analysed.

Results: Patients in the early IH group were the most severely injured. They had the highest TIL levels, had the highest mortality (48%) and the highest rate of unfavourable outcome (65%) followed by the late IH group (20% and 57%) and the no IH group (23% and 36%). Duration of IH correlated significantly with hospital mortality. IH was an independent predictor of mortality and unfavourable outcome after adjusting for age, Glasgow Coma Scale score, and Abbreviated Injury Score "head".

Conclusion: Intracranial hypertension with early onset is independently associated with significantly worse outcome in patients with severe TBI. The total duration of IH shows a significant correlation to mortality.

Citing Articles

Guidelines for Neuroprognostication in Critically Ill Adults with Moderate-Severe Traumatic Brain Injury.

Muehlschlegel S, Rajajee V, Wartenberg K, Alexander S, Busl K, Creutzfeldt C Neurocrit Care. 2024; 40(2):448-476.

PMID: 38366277 PMC: 10959796. DOI: 10.1007/s12028-023-01902-2.


Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial.

van Erp I, van Essen T, Fluiter K, van Zwet E, van Vliet P, Baas F Trials. 2021; 22(1):874.

PMID: 34863258 PMC: 8642972. DOI: 10.1186/s13063-021-05833-1.


The Effect of Timing of Intracranial Pressure Monitor Placement in Patients with Severe Traumatic Brain Injury.

Hoffman H, Bunch K, Protas M, Chin L Neurocrit Care. 2020; 34(1):167-174.

PMID: 32504255 DOI: 10.1007/s12028-020-01002-5.


Refeeding syndrome: multimodal monitoring and clinical manifestation of an internal severe neurotrauma.

Sundstrom N, Brorsson C, Karlsson M, Wiklund U, Koskinen L J Clin Monit Comput. 2020; 35(3):569-576.

PMID: 32363496 PMC: 7223118. DOI: 10.1007/s10877-020-00513-y.


Changes in Posttraumatic Brain Edema in Craniectomy-Selective Brain Hypothermia Model Are Associated With Modulation of Aquaporin-4 Level.

Szczygielski J, Glameanu C, Muller A, Klotz M, Sippl C, Hubertus V Front Neurol. 2018; 9:799.

PMID: 30333785 PMC: 6176780. DOI: 10.3389/fneur.2018.00799.